{"_id":"zfdZpjQ9pdyqBwh6R","bibbaseid":"jacquet-lardyclaud-pistilli-franck-cottu-delaloge-debled-vanlemmens-etal-endocrinetherapyorchemotherapyasfirstlinetherapyinhormonereceptorpositiveher2negativemetastaticbreastcancerpatients-2018","author_short":["Jacquet, E.","Lardy-Cléaud, A.","Pistilli, B.","Franck, S.","Cottu, P.","Delaloge, S.","Debled, M.","Vanlemmens, L.","Leheurteur, M.","Guizard, A.","Laborde, L.","Uwer, L.","Jacot, W.","Berchery, D.","Desmoulins, I.","Ferrero, J.","Perrocheau, G.","Courtinard, C.","Brain, E.","Chabaud, S.","Robain, M.","Bachelot, T."],"bibdata":{"bibtype":"article","type":"article","title":"Endocrine therapy or chemotherapy as first-line therapy in hormone receptor–positive HER2-negative metastatic breast cancer patients","volume":"95","issn":"09598049","url":"https://linkinghub.elsevier.com/retrieve/pii/S0959804918307317","doi":"10.1016/j.ejca.2018.03.013","language":"en","urldate":"2021-09-15","journal":"European Journal of Cancer","author":[{"propositions":[],"lastnames":["Jacquet"],"firstnames":["E."],"suffixes":[]},{"propositions":[],"lastnames":["Lardy-Cléaud"],"firstnames":["A."],"suffixes":[]},{"propositions":[],"lastnames":["Pistilli"],"firstnames":["B."],"suffixes":[]},{"propositions":[],"lastnames":["Franck"],"firstnames":["S."],"suffixes":[]},{"propositions":[],"lastnames":["Cottu"],"firstnames":["P."],"suffixes":[]},{"propositions":[],"lastnames":["Delaloge"],"firstnames":["S."],"suffixes":[]},{"propositions":[],"lastnames":["Debled"],"firstnames":["M."],"suffixes":[]},{"propositions":[],"lastnames":["Vanlemmens"],"firstnames":["L."],"suffixes":[]},{"propositions":[],"lastnames":["Leheurteur"],"firstnames":["M."],"suffixes":[]},{"propositions":[],"lastnames":["Guizard"],"firstnames":["A.V."],"suffixes":[]},{"propositions":[],"lastnames":["Laborde"],"firstnames":["L."],"suffixes":[]},{"propositions":[],"lastnames":["Uwer"],"firstnames":["L."],"suffixes":[]},{"propositions":[],"lastnames":["Jacot"],"firstnames":["W."],"suffixes":[]},{"propositions":[],"lastnames":["Berchery"],"firstnames":["D."],"suffixes":[]},{"propositions":[],"lastnames":["Desmoulins"],"firstnames":["I."],"suffixes":[]},{"propositions":[],"lastnames":["Ferrero"],"firstnames":["J.M."],"suffixes":[]},{"propositions":[],"lastnames":["Perrocheau"],"firstnames":["G."],"suffixes":[]},{"propositions":[],"lastnames":["Courtinard"],"firstnames":["C."],"suffixes":[]},{"propositions":[],"lastnames":["Brain"],"firstnames":["E."],"suffixes":[]},{"propositions":[],"lastnames":["Chabaud"],"firstnames":["S."],"suffixes":[]},{"propositions":[],"lastnames":["Robain"],"firstnames":["M."],"suffixes":[]},{"propositions":[],"lastnames":["Bachelot"],"firstnames":["T."],"suffixes":[]}],"month":"May","year":"2018","pages":"93–101","bibtex":"@article{jacquet_endocrine_2018,\n\ttitle = {Endocrine therapy or chemotherapy as first-line therapy in hormone receptor–positive {HER2}-negative metastatic breast cancer patients},\n\tvolume = {95},\n\tissn = {09598049},\n\turl = {https://linkinghub.elsevier.com/retrieve/pii/S0959804918307317},\n\tdoi = {10.1016/j.ejca.2018.03.013},\n\tlanguage = {en},\n\turldate = {2021-09-15},\n\tjournal = {European Journal of Cancer},\n\tauthor = {Jacquet, E. and Lardy-Cléaud, A. and Pistilli, B. and Franck, S. and Cottu, P. and Delaloge, S. and Debled, M. and Vanlemmens, L. and Leheurteur, M. and Guizard, A.V. and Laborde, L. and Uwer, L. and Jacot, W. and Berchery, D. and Desmoulins, I. and Ferrero, J.M. and Perrocheau, G. and Courtinard, C. and Brain, E. and Chabaud, S. and Robain, M. and Bachelot, T.},\n\tmonth = may,\n\tyear = {2018},\n\tpages = {93--101},\n}\n\n","author_short":["Jacquet, E.","Lardy-Cléaud, A.","Pistilli, B.","Franck, S.","Cottu, P.","Delaloge, S.","Debled, M.","Vanlemmens, L.","Leheurteur, M.","Guizard, A.","Laborde, L.","Uwer, L.","Jacot, W.","Berchery, D.","Desmoulins, I.","Ferrero, J.","Perrocheau, G.","Courtinard, C.","Brain, E.","Chabaud, S.","Robain, M.","Bachelot, T."],"key":"jacquet_endocrine_2018","id":"jacquet_endocrine_2018","bibbaseid":"jacquet-lardyclaud-pistilli-franck-cottu-delaloge-debled-vanlemmens-etal-endocrinetherapyorchemotherapyasfirstlinetherapyinhormonereceptorpositiveher2negativemetastaticbreastcancerpatients-2018","role":"author","urls":{"Paper":"https://linkinghub.elsevier.com/retrieve/pii/S0959804918307317"},"metadata":{"authorlinks":{}},"html":""},"bibtype":"article","biburl":"https://bibbase.org/zotero/iagogv","dataSources":["ovn29uG6Mbp3JWCRR"],"keywords":[],"search_terms":["endocrine","therapy","chemotherapy","first","line","therapy","hormone","receptor","positive","her2","negative","metastatic","breast","cancer","patients","jacquet","lardy-cléaud","pistilli","franck","cottu","delaloge","debled","vanlemmens","leheurteur","guizard","laborde","uwer","jacot","berchery","desmoulins","ferrero","perrocheau","courtinard","brain","chabaud","robain","bachelot"],"title":"Endocrine therapy or chemotherapy as first-line therapy in hormone receptor–positive HER2-negative metastatic breast cancer patients","year":2018}